Trial updateOphthalmology
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
Active, not recruiting. Phase 3. Registered enrolment: 1500. Novo Nordisk A/S
Why it matters
Track this study through NCT03811561. No results are posted in this registry record.
The study at a glance
- Registry status
- Active, not recruiting
- Phase
- Phase 3
- Registered enrolment
- 1500
- Results posted
- No
- Sponsor
- Novo Nordisk A/S
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.
References (1)
Source date: 9 Sept 2026 · United States · Brazil · Bulgaria · Canada · Czechia · Germany · Greece · India · Israel · Latvia · Mexico · Poland · Portugal · Romania · Russia · Serbia · Slovakia · Spain · United Kingdom